APA (7th ed.) Citation

Maggisano, M., Mondini, L., Chernovsky, M., Confalonieri, P., Salton, F., Reccardini, N., . . . Ruaro, B. (2024). Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease. Pharmaceuticals (14248247), 17(9), 1147. https://doi.org/10.3390/ph17091147

Chicago Style (17th ed.) Citation

Maggisano, Marta, et al. "Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease." Pharmaceuticals (14248247) 17, no. 9 (2024): 1147. https://doi.org/10.3390/ph17091147.

MLA (9th ed.) Citation

Maggisano, Marta, et al. "Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease." Pharmaceuticals (14248247), vol. 17, no. 9, 2024, p. 1147, https://doi.org/10.3390/ph17091147.